Joseph F. Fraumeni Jr. Dies at 93 After Pioneering Genetic Links to Cancer
Updated
Updated · The New York Times · Jul 9
Joseph F. Fraumeni Jr. Dies at 93 After Pioneering Genetic Links to Cancer
1 articles · Updated · The New York Times · Jul 9
Summary
Joseph F. Fraumeni Jr., a National Cancer Institute leader who helped uncover one of the first gene-linked cancer syndromes, died June 22 in McLean, Virginia, at 93.
That work helped launch cancer genetics and a field that has since identified more than 120 genes that predispose people to cancer.
At the NCI in Bethesda, Fraumeni also advanced research on environmental and lifestyle cancer risks and steered grants that applied molecular biology to population and family studies.
Colleagues credited him as a founder of molecular epidemiology, the discipline linking past exposures and inherited risk to present disease patterns.
Could screening newborns for cancer genes, a legacy of his work, become the next major breakthrough in cancer prevention?
Decades after a 'guardian' gene was linked to cancer, has its newly discovered partner unlocked the key to a targeted cure?
Dr. Joseph F. Fraumeni Jr. (1933–2026): Pioneering Cancer Epidemiologist and Architect of Hereditary Cancer Research
Overview
Dr. Joseph F. Fraumeni Jr., a pioneering cancer epidemiologist, passed away on June 22, 2026, marking the end of an era for cancer research. He was recognized as the founder of molecular epidemiology, shaping our understanding of cancer’s genetic and environmental origins. By championing the use of emerging molecular biology technologies in the 1970s and 1980s, he directed crucial grants at the National Cancer Institute that propelled innovative research forward. His foundational work left an indelible mark on public health, inspiring new generations to build on his legacy and continue advancing cancer prevention and treatment.